| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Medicus Pharma Ltd.
13G/A
Amendment 1
MDCX · 58471K202
|
4.5% |
8/12/2025
Event 6/30/2025
|
|||
| John Hathaway | 4.5% | ||||
| SkinJect Partners LLC | 4.5% | ||||
|
Medicus Pharma Ltd.
13G
MDCX · 58471K202
|
6.8% |
2/10/2025
Event 12/31/2024
|
|||
| John Hathaway | 6.8% | ||||
| SkinJect Partners LLC | 6.8% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.